机构

• 上海药物研究所 [3]
• 合肥物质科学研究院 [3]

采集方式

• OAI收割 [6]

内容类型

• 期刊论文 [6]

发表日期

• 2022 [2]
• 2020 [3]
• 2014 [1]

学科主题

筛选

浏览/检索结果: 共6条，第1-6条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan   |  收藏  |  浏览/下载：128/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   Design, synthesis and evaluation of the Brigatinib analogues as potent inhibitors against tertiary EGFR mutants (EGFR(del19/T790M/C797S) and EGFR(L858R/T790M/C797S)) 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 卷号: 72, 页码: 11 作者:  Fang, Haotian;  Wu, Yingming;  Xiao, Qitao;  He, Dongbo;  Zhou, Tongrui   |  收藏  |  浏览/下载：122/0  |  提交时间：2022/08/16 Non-small cell lung cancer  EGFR  Triple mutations  C797S  EGFR-TKIs   Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun   |  收藏  |  浏览/下载：76/0  |  提交时间：2020/10/26 tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)   EGFR exon 20 insertion mutations in non-small cell lung cancer 期刊论文  OAI收割 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wang, Fenfang;  Li, Chenghui;  Wu, Qihuan;  Lu, Hongyang   |  收藏  |  浏览/下载：59/0  |  提交时间：2020/11/26 EGFR exon 20 insertion mutations  non-small cell lung cancer (NSCLC)  EGFR-TKIs  structural features  clinical features  treatment  prognosis   Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC 期刊论文  OAI收割 JOURNAL OF CANCER, 2020, 卷号: 11, 期号: 1, 页码: 241-250 作者:  Zhang, Yan;  Yang, Xinying;  Liu, Hongchun;  Cai, Minghui;  Yang Shentu   |  收藏  |  浏览/下载：74/0  |  提交时间：2020/07/01 EGFR-TKIs  NSCLC  lymphangiogenesis  JAK/STAT3  LYVE-1   Pharmacokinetics of icotinib，a novel anti-tumor agent，and its tissue distribution in preclinical species 期刊论文  OAI收割 Chinese Journal New Drugs, 2014, 卷号: 23, 期号: 2, 页码: 235-240 作者:  Zhang Yifan;  Guan Zhongmin;  Chen Xiaoyan;  Hu Yunyan;  Wang Yinxiang   |  收藏  |  浏览/下载：36/0  |  提交时间：2019/01/08 icotinib  pharmacokinetics  EGFR-TKIs